Regeneron Pharmaceuticals Inc (REGN)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	4,047,100	4,738,900	8,946,800	3,576,600	2,209,800
Revenue	US$ in thousands	13,044,200	12,113,500	16,014,400	8,440,200	7,833,200
Operating profit margin		31.03%	39.12%	55.87%	42.38%	28.21%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $4,047,100K ÷ $13,044,200K
= 31.03%

Regeneron Pharmaceuticals, Inc.'s operating profit margin has displayed variability over the past five years as shown in the table. The trend indicates a decline in operating profit margin from 55.38% in 2021 to 32.26% in 2023. This suggests a decrease in the company's ability to generate profits from its core operations relative to its revenue.

The significant drop in operating profit margin from 2021 to 2023 raises concerns about the company's operational efficiency and profitability. It may indicate challenges such as increasing costs, declining revenue growth, or inefficiencies in production processes. Investors and stakeholders may be interested in understanding the factors contributing to this decline to assess the company's financial health and future prospects.